The legacy of Viagra, and its creator copyright, presents a complex case study for investors. Originally a blockbuster drug, producing billions in income, its intellectual property lapse created a deluge of lower-priced alternatives , significantly diminishing its position . While some pharmaceutical companies may seek to capitalize on related trea